Loading...
Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells
Perry, John M. ; Tao, Fang ; Roy, Anuradha ; Lin, Tara ; He, Xi C. ; Chen, Shiyuan ; Lu, Xiuling ; Nemechek, Jacqelyn ; Ruan, Linhao ; Yu, Xiazhen ... show 10 more
Perry, John M.
Tao, Fang
Roy, Anuradha
Lin, Tara
He, Xi C.
Chen, Shiyuan
Lu, Xiuling
Nemechek, Jacqelyn
Ruan, Linhao
Yu, Xiazhen
Citations
Altmetric:
Abstract
Leukaemia stem cells (LSCs) underlie cancer therapy resistance but targeting these cells remains difficult. The Wnt–β-catenin and PI3K–Akt pathways cooperate to promote tumorigenesis and resistance to therapy. In a mouse model in which both pathways are activated in stem and progenitor cells, LSCs expanded under chemotherapy-induced stress. Since Akt can activate β-catenin, inhibiting this interaction might target therapy-resistant LSCs. High-throughput screening identified doxorubicin (DXR) as an inhibitor of the Akt–β-catenin interaction at low doses. Here we repurposed DXR as a targeted inhibitor rather than a broadly cytotoxic chemotherapy. Targeted DXR reduced Akt-activated β-catenin levels in chemoresistant LSCs and reduced LSC tumorigenic activity. Mechanistically, β-catenin binds multiple immune-checkpoint gene loci, and targeted DXR treatment inhibited expression of multiple immune checkpoints specifically in LSCs, including PD-L1, TIM3 and CD24. Overall, LSCs exhibit distinct properties of immune resistance that are reduced by inhibiting Akt-activated β-catenin. These findings suggest a strategy for overcoming cancer therapy resistance and immune escape.
Description
Date
2020-04-20
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Research
Files
Loading...
Perry_2020.pdf
Adobe PDF, 4 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Cancer immunotherapy, Cancer stem cells, Cancer therapeutic resistance, Cell signaling
Citation
Perry, J.M., Tao, F., Roy, A. et al. Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells. Nat Cell Biol 22, 689–700 (2020). https://doi.org/10.1038/s41556-020-0507-y
